|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 219.68 USD | -2.52% |
|
-4.53% | -3.86% |
| 03-10 | AbbVie Inc. Presents at Leerink Global Healthcare Conference 2026, Mar-10-2026 11:20 AM | |
| 03-09 | AbbVie says CEO Robert Michael's 2025 total compensation was $32.5 million - SEC filing | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5d. change | Varia. Jan 1. | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ABBVIE INC. | Other Pharmaceuticals | -2.52% | -4.53% | -3.86% | +3.74% | +99.24% | 388B |  | |  |
Technical Rankings Surperformance
- Stock Market
- Equities
- ABBV Stock
- Charts AbbVie Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition